CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $41,000 | -98.5% | 101,100 | -92.8% | 0.00% | -100.0% |
Q3 2019 | $2,827,000 | +108.5% | 1,413,475 | +125.1% | 0.03% | +116.7% |
Q2 2019 | $1,356,000 | -11.1% | 628,000 | +30.2% | 0.01% | -7.7% |
Q1 2019 | $1,525,000 | +27.0% | 482,500 | 0.0% | 0.01% | +18.2% |
Q4 2018 | $1,201,000 | +17.2% | 482,500 | +89.3% | 0.01% | +57.1% |
Q3 2018 | $1,025,000 | – | 254,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 250,000 | $103,000 | 0.68% |
Tamarack Advisers, LP | 2,500,000 | $1,019,000 | 0.23% |
Virtu Financial LLC | 287,972 | $118,000 | 0.01% |
ARS Investment Partners, LLC | 147,818 | $61,000 | 0.01% |
Pacifica Partners Inc. | 2,665 | $1,000 | 0.00% |
OXFORD ASSET MANAGEMENT LLP | 116,653 | $48,000 | 0.00% |
K.J. Harrison & Partners Inc | 12,860 | $5,000 | 0.00% |
TORONTO DOMINION BANK | 153 | $0 | 0.00% |
SCOTIA CAPITAL INC. | 19,000 | $8,000 | 0.00% |
MORGAN STANLEY | 99,852 | $41,000 | 0.00% |